Lifitegrast OverviewLifitegrast (trade name Xiidra) is an FDA approved drug indicated for the treatment of signs and symptoms of dry eye, a syndrome called keratoconjunctivitis sicca. Lifitegrast reduces inflammation by inhibiting inflammatory cell binding. It is often used in conjunction with ciclosporin (Ikervis or Restasis) for dry eye treatment including meibomian gland dysfunction and inflammatory dry eye. Contents 1 Adverse effects 2 Pharmacology 2.1 Mechanism of action 3 History ...
Read more Lifitegrast Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lifitegrast
Recent Lifitegrast Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution/drops: 5%